Related Experiment Videos
Intravenous metronidazole therapy for Bacteroides fragilis meningitis
Abstract:
A 69-year-old man developed meningitis due to Bacteroides fragilis and Streptococcus MG-intermedius, which progressed during chloramphenicol and nafcillin therapy to the extent that he seemed near death, with frank pus covering the spinal cord at surgery. Treatment with intravenous metronidazole and penicillin G was curative. After multiple trauma, a 20-year-old man developed meningitis due to Escherichia coli and B fragilis. He failed to respond to chloramphenicol alone, but responded to combined treatment with chloramphenicol and metronidazole. The right frontal sinus and epidural space abscesses were drained and a right frontal lobe abscess was excised. Metronidazole may be a uniquely effective agent for treatment of meningitis due to susceptible strains of Bacteroides fragilis.
Insights
Metronidazole is a highly effective treatment for Bacteroides fragilis meningitis, a severe bacterial infection. This antibiotic shows promise in curing difficult cases where other treatments fail, offering hope for patients with this serious condition.
Area of Science:
- Infectious Diseases
- Neuroscience
- Pharmacology
Background:
- Bacterial meningitis, particularly involving Bacteroides fragilis, presents a significant therapeutic challenge.
- Standard antibiotic regimens may be insufficient for severe or polymicrobial meningitis.
- The efficacy of metronidazole in central nervous system infections requires further investigation.
Observation:
- A 69-year-old male patient with meningitis caused by Bacteroides fragilis and Streptococcus MG-intermedius showed clinical deterioration despite chloramphenicol and nafcillin therapy.
- A 20-year-old male patient with meningitis due to Escherichia coli and B. fragilis did not respond to chloramphenicol alone.
- Both patients experienced positive outcomes with the addition of metronidazole to their treatment regimens.
Findings:
- Intravenous metronidazole combined with penicillin G was curative in the first patient with severe B. fragilis and S. MG-intermedius meningitis.
- Combined chloramphenicol and metronidazole therapy led to a positive response in the second patient with polymicrobial meningitis and brain abscesses.
- Metronidazole demonstrated potential as a uniquely effective agent against susceptible strains of Bacteroides fragilis in meningitis.
Implications:
- Metronidazole should be considered as a key therapeutic option for Bacteroides fragilis meningitis, especially in refractory or severe cases.
- This finding may influence treatment guidelines for meningitis caused by anaerobic bacteria.
- Further clinical studies are warranted to confirm the broad efficacy and optimal use of metronidazole in central nervous system infections.